Skip to main content
. 2021 Feb 25;22(5):2301. doi: 10.3390/ijms22052301

Table 1.

Biomarkers for diabetic neuropathy mentioned in this review.

Biomarker
Candidate
Sample Source Quantitative Method Function Changes during Neuropathy Literature
(a) AGEs related
Methylglyoxal Human serum HPLC Post-translational modification of voltage-gated sodium channel Nav 1.8 causes hyperalgesia. In addition, it activates TRPA1 and induces temperature and mechanical hyperalgesia. When administered to mice, hyperalgesia due to thermal and mechanical stimulation is induced. [14,15,16,17,18,19,20]
Glyoxalase I (GLO I) Mouse DRG
Human serum
Colorimetric method A rate-limiting enzyme that decomposes reactive dicarbonyls such as methylglyoxal The neuropathic symptoms observed in diabetic conditions are significantly suppressed in mice with high GLO I activity. In humans, decreased GLO I activity is also significantly correlated with the frequency of painful neuropathy [21,22,23,24,25]
(b) Inflammation-related molecules
TNF-α Human serum ELISA Expression of cell adhesion molecules and induction of apoptosis Increased inflammatory mediator It is elevated in type 2 diabetic patients in the control group and in the diabetic and neuropathy group compared to the diabetic group [28,29]
TLR4 Human
peripheral
blood
mononuclear cells
qPCR Receptors involved in innate
immunity
It is elevated in type 2 diabetic patients in the control group and in the diabetic and neuropathy group compared to the diabetic group [30,31,32,33,34]
Adiponectin Human serum ELISA Adipocytokines produced and secreted by adipocytes There is a significant difference between the control group and the diabetic group with neuropathy compared with the control group in type 2 diabetic patients (the distinction differs depending on the report). [36,37,38]
miR-146a Human Serum
Mouse DRG
qPCR Negative feedback on inflammatory response It is elevated in patients with type 2 diabetes, but its association with neuropathy has not been investigated. In diabetic neuropathy mice, the expression level in the DRG is reduced, and the forced expression in the DRG after culture acquires resistance to hyperglycemia-induced apoptosis. [40,41]
(c)Molecules associated with nerve damage
Nerve-specificenolase (NSE) Human serum ELISA Glycolytic enzymes specific to nerve tissue
(Leakage due to nerve damage)
It is elevated in type 1 and type 2 diabetic patients compared to the control group, especially in the group with neuropathy. [47,48]
Semaphorin Mouse
sciatic nerve
qPCR Nerve axon elongation guidance factor These mRNAs are induced in the sciatic nerve in a rat sciatic nerve
ligation model.
[52,53,54,55]
(d) Molecules involved in neuroprotection
NGF Human serum ELISA Neurotrophic factors involved in nerve regeneration It is lower in type 2 diabetic patients in the control group and in the diabetic and neuropathy group than in the diabetic group [56,57,58,59]
HSP27 Human serum ELISA Cell protective factors in the presence of stress It is elevated in type 1 and type 2 diabetic patients compared to the control group, especially in the group with neuropathy. [60,61,62,63,64]